9 February 2016 - The EMA and the European Commission have prepared an implementation plan for centrally authorised medicines to guide applicants and marketing-authorisation holders in meeting the requirements of a new regulation of the Falsified Medicines Directive.

For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/02/news_detail_002467.jsp&mid=WC0b01ac058004d5c1